Results 141 to 150 of about 9,692 (263)

Migration status and urologic health inequities: a scoping review. [PDF]

Curr Opin Urol
Goodarzi K, Miszczyk M, Karakiewicz PI, Reis LO, Shariat SF.   +4 more
europepmc   +1 more source

ZW4864‐mediated inhibition of the β‐catenin/BCL9/BCL9L complex reveals therapeutic potential in bladder cancer

Molecular Oncology, EarlyView.
BCL9 and BCL9L drive bladder cancer progression by enhancing β‐catenin signaling, promoting proliferation, migration, invasion, and organoid growth. Genetic depletion of BCL9(L) suppresses malignant phenotypes, while pharmacological disruption of the β‐catenin/BCL9(L) complex with ZW4864 inhibits canonical Wnt signaling and tumor‐associated cellular ...
Roland Kotolloshi, Mandy Berndt‐Paetz, Eileen Lerner, Gregoire Najjar, Anca Azoitei, Krishna Pal Singh, Shailendra Kumar Gupta, Olaf Wolkenhauer, Cagatay Günes, Otmar Huber, Marc‐Oliver Grimm, Daniel Steinbach   +11 more
wiley   +1 more source

Comparison of LDH activity and LDH-M to predict death in patients with acetaminophen-induced acute liver failure. [PDF]

EXCLI J
Bhadra D, Rule JA, Lee WM, McGill MR.
europepmc   +1 more source

From tumor‐centric to ecosystem‐based hypotheses in brain tumor research and care

Molecular Oncology, EarlyView.
Primary brain tumors, whether in adults or children, present a major challenge because of their dramatic prognosis and the ongoing lack of efficient therapeutic approaches. In recent years, a shift has occurred from tumor‐centric concepts to a more holistic view of these tumors as dynamic ecosystems.
Julie Gavard, Flavie Bénard, Eva Billat, Margaux Le Guyon, Victoria Maltret, Laura Merlet, Chloé Astrid Walter, Tony Avril, Eric Chevet   +8 more
wiley   +1 more source

ASO Author Reflections: Type 2 Diabetes Mellitus and Insulin-Dependence as Determinants of Adverse In-Hospital Outcomes After Partial or Radical Nephrectomy. [PDF]

Ann Surg Oncol
Filzmayer M, Nicolazzini M, Catanzaro C, Polverino F, Petix M, Quarta L, Goyal JA, Volpe A, Schiavina R, Longo N, Musi G, Briganti A, Shariat SF, Wenzel M, Kosiba M, Humke C, Saad F, Chun FK, Karakiewicz PI.   +18 more
europepmc   +1 more source

Prognostication

Public Health and Emergency, 2016
Amy Allen Case, Michelle M. Walter
openaire   +1 more source

Preoperative circulating tumor cells integrated with imaging analysis for prognostic evaluation in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
Detecting circulating tumor cells (CTCs) in blood before surgery may help predict outcomes in patients with head and neck squamous cell carcinoma (HNSCC). Here, we show when combined with tumor size and lymph node involvement from routine imaging, CTC status identifies high‐risk patients with poorer survival—offering a simple, minimally invasive tool ...
Susanne Flach, Gizem Abaci, Tom Huberty, Axel Lechner, Lukas Käsmann, Jens Ricke, Sophia Stöcklein, Martin Canis, Philipp Baumeister, Marianna Alunni‐Fabbroni   +9 more
wiley   +1 more source

Enhancing photothermal therapy effectiveness via tartrazine-induced optical clearing of biological tissues. [PDF]

Sci Rep
Minopoli A, Evangelista D, Marras M, Perini G, Augello A, Palmieri V, De Spirito M, Papi M.   +7 more
europepmc   +1 more source

Epigenetic silencing of the liver‐specific lncRNA LUNAR promotes liver cancer progression via NOTCH activation

Molecular Oncology, EarlyView.
LUNAR is a liver‐specific long noncoding RNA (lncRNA) that is highly expressed in normal liver but becomes epigenetically silenced in hepatocellular carcinoma through promoter hypermethylation. Loss of LUNAR is associated with NOTCH activation, epithelial–mesenchymal transition, and metastasis, whereas restoring LUNAR restrains metastatic progression ...
Se Ha Jang, Hyung Seok Kim, Geum Ok Baek, Moon Gyeong Yoon, Su In Lee, Jee‐Yeong Jeong, Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun   +9 more
wiley   +1 more source

Sex determining region Y box protein 2 (SOX2) expression, alteration, regulation and its diagnostics, prognostics and therapeutics in lung cancer. [PDF]

Discov Oncol
Jiang X, Zheng M, Zhang L, Xu D, Cheng J, Deng H, Wei C, Xian J, Xu F, Maghsoudloo M, Li D, Ma W, Fu J.   +12 more
europepmc   +1 more source